{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:52Z","timestamp":1772120032186,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04000-1","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T12:02:16Z","timestamp":1723809736000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term follow-up of treatment outcomes in Graves\u2019 disease and toxic nodular disease"],"prefix":"10.1007","volume":"87","author":[{"given":"David","family":"Ver\u00edssimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Vinhais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Ivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o N.","family":"e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Passos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o J.","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mafalda","family":"Marcelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"10","key":"4000_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10), 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"issue":"4","key":"4000_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","volume":"11","author":"WM Wiersinga","year":"2023","unstructured":"W.M. Wiersinga, K.G. Poppe, G. Effraimidis, Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diab. Endocrinol. 11(4), 282\u2013298 (2023). https:\/\/doi.org\/10.1016\/S2213-8587(23)00005-0","journal-title":"Lancet Diab. Endocrinol."},{"key":"4000_CR3","doi-asserted-by":"publisher","unstructured":"D.M. Smith, S. Dutta, F. Ahmed, M.A. Thaha, Change in practice over four decades in the management of Graves\u2019 disease in Scotland. J. Thyroid Res. 9697849 (2016). https:\/\/doi.org\/10.1155\/2016\/9697849","DOI":"10.1155\/2016\/9697849"},{"issue":"4","key":"4000_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"G.J. Kahaly, L. Bartalena, L. Heged\u00fcs, L. Leenhardt, K. Poppe, S.H. Pearce, European Thyroid Association guideline for the management of graves\u2019 hyperthyroidism. Eur. Thyroid J. 7(4), 167\u2013186 (2018). https:\/\/doi.org\/10.1159\/000490384","journal-title":"Eur. Thyroid J."},{"key":"4000_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-018-0322-7","volume":"18","author":"E Fanning","year":"2018","unstructured":"E. Fanning, W.J. Inder, E. Mackenzie, Radioiodine treatment for graves\u2019 disease: a 10-year Australian cohort study. BMC Endocr. Disord. 18, 94 (2018). https:\/\/doi.org\/10.1186\/s12902-018-0322-7","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"4000_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1530\/EJE-16-0986","volume":"176","author":"T Struja","year":"2017","unstructured":"T. Struja, M. Kaeslin, F. Boesiger, R. Jutzi, N. Imahorn, A. Kutz et al. External validation of the GREAT score to predict relapse risk in Graves\u2019 disease: results from a multicenter, retrospective study with 741 patients. Eur. J. Endocrinol. 176(4), 413\u2013419 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0986","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"4000_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1089\/thy.2019.0180","volume":"29","author":"F Azizi","year":"2019","unstructured":"F. Azizi, A. Amouzegar, M. Tohidi, M. Hedayati, D. Khalili, L. Cheraghi et al. Increased remission rates after long-term methimazole therapy in patients with Graves\u2019 disease: results of a randomized clinical trial. Thyroid 29(9), 1192\u2013200 (2019). https:\/\/doi.org\/10.1089\/thy.2019.0180","journal-title":"Thyroid"},{"key":"4000_CR8","doi-asserted-by":"publisher","unstructured":"R. Lertwattanarak, T. Kunavisarut, S. Sriussadaporn, benefits of long-term continuation of low-dose methimazole therapy in the prevention of recurrent hyperthyroidism in graves\u2019 hyperthyroid patients: a randomized prospective controlled study. Int. J. Endocrinol. 2022, 1705740 (2022). https:\/\/doi.org\/10.1155\/2022\/1705740","DOI":"10.1155\/2022\/1705740"},{"issue":"11","key":"4000_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/thy.2019.0085","volume":"29","author":"G Sj\u00f6lin","year":"2019","unstructured":"G. Sj\u00f6lin, M. Holmberg, O. T\u00f6rring, K. Bystr\u00f6m, S. Khamisi, D. de Laval et al. The long-term outcome of treatment for Graves\u2019 Hyperthyroidism. Thyroid 29(11), 1545\u20131557 (2019). https:\/\/doi.org\/10.1089\/thy.2019.0085","journal-title":"Thyroid"},{"issue":"1","key":"4000_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6730","volume":"12","author":"HA Zarif","year":"2020","unstructured":"H.A. Zarif, S.S. Alam, A. Baashar, A. Alsharif, M. Alhilabi, Comparison between the treatment modalities for Graves\u2019 disease at King Abdulaziz Medical City, Jeddah. Cureus 12(1), e6730 (2020). https:\/\/doi.org\/10.7759\/cureus.6730","journal-title":"Cureus"},{"issue":"4","key":"4000_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/thy.2016.0343","volume":"27","author":"V Sundaresh","year":"2017","unstructured":"V. Sundaresh, J.P. Brito, P. Thapa, R.S. Bahn, M.N. Stan, Comparative effectiveness of treatment choices for Graves\u2019 hyperthyroidism: a historical cohort study. Thyroid 27(4), 497\u2013505 (2017). https:\/\/doi.org\/10.1089\/thy.2016.0343","journal-title":"Thyroid"},{"issue":"9","key":"4000_CR12","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/jc.2013-1954","volume":"98","author":"V Sundaresh","year":"2013","unstructured":"V. Sundaresh, J.P. Brito, Z. Wang, L.J. Prokop, M.N. Stan, M.H. Murad et al. Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis. J. Clin. Endocrinol. Metab. 98(9), 3671\u20133677 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1954","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"4000_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12020-013-9895-0","volume":"44","author":"P Anagnostis","year":"2013","unstructured":"P. Anagnostis, F. Adamidou, S.A. Polyzos, S. Katergari, E. Karathanasi, C. Zouli et al. Predictors of long-term remission in patients with Graves\u2019 disease: a single center experience. Endocrine 44(2), 448\u2013453 (2013). https:\/\/doi.org\/10.1007\/s12020-013-9895-0","journal-title":"Endocrine"},{"issue":"3","key":"4000_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/EJE-13-0811","volume":"170","author":"E Mohlin","year":"2014","unstructured":"E. Mohlin, H.F. Nystr\u00f6m, M. Eliasson, Long-term prognosis after medical treatment of Graves\u2019 disease in a northern Swedish population 2000\u20132010. Eur. J. Endocrinol. 170(3), 419\u2013427 (2014). https:\/\/doi.org\/10.1530\/EJE-13-0811","journal-title":"Eur. J. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04000-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:52:36Z","timestamp":1737013956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4000"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04000-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4581035\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by our center\u2019s ethics committee and complies with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Confidentiality was kept throughout the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}